Drug Trial Radar · NCT05270863
Safety and Efficacy Study BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic or Pseudophakic Presbyopia
Last checked: Nov 20, 2026Latest source record: Oct 15, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
182
Actual
Start
Mar 30, 2022
Primary completion
Mar 17, 2023
Study completion Apr 10, 2023
Sponsor
- Lead sponsor
- Visus TherapeuticsAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 8, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 45 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia
Conditions
- Presbyopia
Interventions
BRIMOCHOL™ PFDrug
A single drop in each eye at a visit.
Carbachol PFDrug
A single drop in each eye at a visit.
Brimonidine tartrateDrug
A single drop in each eye at a visit.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Subjects With >=15 Letter Gain Without >=5 Letter Loss in Near Visual AcuityTime frame: Day 1 Hour 1
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Visus Therapeutics Investigative Site
Glendale, California
Visus Therapeutics Investigative Site
Rancho Cordova, California
Visus Therapeutics Investigative Site
Jacksonville, Florida
Visus Therapeutics Investigative Site
Morrow, Georgia
Visus Therapeutics Investigative Site
Roswell, Georgia
Visus Therapeutics Investigative Site
Shawnee Mission, Kansas
Visus Therapeutics Investigative Site
Kansas City, Missouri
Visus Therapeutics Investigative Site
Kansas City, Missouri
Visus Therapeutics Investigative Site
Pittsburgh, Pennsylvania
Visus Therapeutics Investigative Site
Memphis, Tennessee
Visus Therapeutics Investigative Site
Memphis, Tennessee
Visus Therapeutics Investigative Site
Cedar Park, Texas
Visus Therapeutics Investigative Site
Houston, Texas
Visus Therapeutics Investigative Site
San Antonio, Texas
Visus Therapeutics Investigative Site
Ogden, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.